My theory is he just learned about leronlimab when it was administered to his father; I don’t think he’s a current shareholder. All of the buzz about his Facebook response started on Friday after market close. He has to notice that his response received 250 likes, so he researches the company and decides to buy-in Monday morning. Once he buys, he can go to the media with the story to pump the stock.

To be clear, I’m just having fun speculating.